NCT05032495

Patient Engagement Study to Evaluate the Use of Biological Therapies for Cardiac Arrhythmias

Patient Directed Strategies for Cardiac Arrhythmia

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 22 (actual)
• Sponsor: Ottawa Heart Institute Research Corporation · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

In this patient engagement study, patients and partners will attend a presentation, group meeting and responding to the survey to help the research team gage the acceptability of using a biological therapy to prevent cardiac arrhythmia. Patient Partners will also help to clarify which outcomes are important to patients, to ensure the selected outcomes align with patient interests.

Detailed description

There will be four study groups: 1. Heart patients who experienced a cardiac arrhythmia while in hospital, 2. Heart patients who did not experience a cardiac arrhythmia while in hospital, 3. Heart patients with an upcoming procedure that have not had a cardiac arrhythmia, 4. Members of the general public. There will be a presentation, two surveys and a team meeting. Results will be compiled and analyzed.

Conditions

• Arrythmia

Interventions

Type	Name	Description
OTHER	Surveys	Surveys to evaluate prior experience, opinions and intervention acceptability.
OTHER	Focus group	To answer any questions and discuss topics covered in the standard presentation.

Timeline

• Start date: 2022-05-01
• Primary completion: 2023-08-31
• Completion: 2023-08-31
• First posted: 2021-09-02
• Last updated: 2024-04-09

Locations

1 site across 1 country: Canada